# Buprenorphine and Naloxone

NDC: 43598-582
Generic name: Buprenorphine and Naloxone
Labeler / Manufacturer: Dr.Reddys Laboratories Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: FILM, SOLUBLE
Routes: BUCCAL, SUBLINGUAL
Marketing started: 20180614

FDA application: ANDA205299

## Active ingredients

- BUPRENORPHINE HYDROCHLORIDE: 8 mg/1
- NALOXONE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43598-582"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43598-582
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=718756d7-0131-b173-6c45-5ee039b311b0